{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:05Z","timestamp":1786649885674,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>Breast cancer is the most common cancer among women worldwide. Science has already proved that some breast cancer genes are inherited from parents. It is generally believed that the probability of cancer diagnosis in carriers of those genes is considerably higher than the normal population. It is in the same direction that modern medicine has introduced prophylactic mastectomy \u2013 one of the key preventive methods which is the focus of the present research. Nevertheless, whether women that have been diagnosed with breast cancer would take this approach depends on their local culture and their set of beliefs. In this regard, the present research was meant to evaluate the acceptability rate of prophylactic mastectomy among women in Iran after they are informed of the positive genetic test results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Six hundred and five healthy women, who had no history of breast cancer, were selected by nonprobability sampling method. A predesigned questionnaire was filled out by the interviewer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Results showed that about 15% of respondents were willing to pick the prophylactic mastectomy in case they are identified as carriers of breast cancer genes. Twenty-two percent of participants with positive family history was agreed with prophylactic mastectomy while in the negative family history group it was about 14%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Preventive mastectomy has a higher rate of acceptability among women who have had a family history of breast cancer. Therefore, it may be concluded that raising public awareness about the advantages of prophylactic mastectomy could help better address breast cancer in Iran.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0973-1482.171363","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T05:33:49Z","timestamp":1469511229000},"page":"915-919","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Iranian women's attitude toward prophylactic mastectomy for breast cancer"],"prefix":"10.4103","volume":"12","author":[{"given":"Keivan","family":"Majidzadeh-A","sequence":"first","affiliation":[{"name":"Cancer Genetics Group, Breast Cancer Research Center, ACECR, Tehran, Iran"},{"name":"Tasnim Biotechnology Research Center, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Farahmand","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group, Breast Cancer Research Center, ACECR, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Akbar","family":"Zare","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group, Breast Cancer Research Center, ACECR, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezvan","family":"Esmaeili","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group, Breast Cancer Research Center, ACECR, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Salehi","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group, Breast Cancer Research Center, ACECR, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Habibi","sequence":"additional","affiliation":[{"name":"Cancer Genetics Group, Breast Cancer Research Center, ACECR, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,7,25]]},"reference":[{"key":"R1-20260109","first-page":"465","article-title":"Hereditary risks of breast cancer. Interaction of genetic factors and hormonal factors","volume":"59","author":"Plu-Bureau","year":"1998","journal-title":"Ann Endocrinol (Paris)"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/0959-8049(94)00455-E","article-title":"BRCA1, BRCA2, BRCA3. A myriad of breast cancer genes","volume":"30A","author":"Bishop","year":"1994","journal-title":"Eur J Cancer"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13","volume":"61","author":"Easton","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijc.20429","article-title":"Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literature","volume":"112","author":"Calderon-Margalit","year":"2004","journal-title":"Int J Cancer"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/pmed.2000.0684","article-title":"Prophylactic surgery decisions and surveillance practices one year following BRCA1\/2 testing","volume":"31","author":"Lerman","year":"2000","journal-title":"Prev Med"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","article-title":"Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation","volume":"355","author":"Meijers-Heijboer","year":"2000","journal-title":"Lancet"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/sj.ejhg.5200418","article-title":"Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast\/ovarian cancer risk and subsequently published guidelines","volume":"8","author":"Julian-Reynier","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1200\/JCO.1998.16.8.2868","article-title":"Decision-making about breast cancer susceptibility testing: How similar are the attitudes of physicians, nurse practitioners, and at-risk women?","volume":"16","author":"Geller","year":"1998","journal-title":"J Clin Oncol"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1200\/JCO.2000.18.11.2250","article-title":"Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer","volume":"18","author":"Meiser","year":"2000","journal-title":"J Clin Oncol"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/1097-0142(20010815)92:4<959::AID-CNCR1406>3.0.CO;2-V","article-title":"Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: Differences among English, French, and Canadian women","volume":"92","author":"Julian-Reynier","year":"2001","journal-title":"Cancer"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"238","DOI":"10.47102\/annals-acadmedsg.V34N3p238","article-title":"Acceptance of prophylactic surgery and chemoprevention of cancer in Singapore \u2013 A survey","volume":"34","author":"See","year":"2005","journal-title":"Ann Acad Med Singapore"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jmg.38.8.540","article-title":"A community based study on intentions regarding predictive testing for hereditary breast cancer","volume":"38","author":"Welkenhuysen","year":"2001","journal-title":"J Med Genet"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/jmg.37.11.866","article-title":"An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling","volume":"37","author":"Metcalfe","year":"2000","journal-title":"J Med Genet"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201612020-00085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:30Z","timestamp":1786647570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201612020-00085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.171363","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}